AJR 2001; 176:603-606
© American Roentgen Ray Society
The Ability of Helical CT to Preoperatively Stage Endometrial Carcinoma
Lara A. Hardesty1,
Jules H. Sumkin1,
Christiane Hakim1,
Christopher Johns1 and
Manju Nath2
1
Department of Radiology, Magee Women's Hospital, University of Pittsburgh, 300
Halket St., Pittsburgh, PA 15213.
2
Department of Pathology, Magee Women's Hospital, University of Pittsburgh,
Pittsburgh, PA 15213.
Received July 19, 2000;
accepted after revision August 30, 2000.
Presented at the annual meeting of the American Roentgen Ray Society,
Washington, DC, May 2000.
Address correspondence to L. A. Hardesty.
Abstract
OBJECTIVE. This study evaluated helical CT as an imaging modality
for preoperative staging of endometrial carcinoma.
MATERIALS AND METHODS. Three radiologists retrospectively and
independently reviewed the preoperative helical CT scans of 25 consecutive
patients with endometrial carcinoma. The presence or absence of deep
myometrial invasion and the presence or absence of cervical involvement were
evaluated on helical CT and compared with pathologic findings at
hysterectomy.
RESULTS. Helical CT has a sensitivity of 83% and a specificity of
42% for the detection of deep myometrial invasion (stage IC). Helical CT has a
sensitivity of 25% and a specificity of 70% for the detection of cervical
involvement (state II). These results compare poorly with those of MR imaging
(sensitivity 92%, specificity 90% for the detection of deep myometrial
invasion; sensitivity 86%, specificity 97% for the detection of cervical
involvement).
CONCLUSION. Helical CT is insensitive and nonspecific compared with
MR imaging for the preoperative staging of endometrial carcinoma. MR imaging
remains the imaging modality of choice.
Introduction
Endometrial carcinoma is the fourth most common cancer in women and is the
most common gynecologic malignancy in the United States
[1]. Endometrial carcinoma is
staged surgically with the International Federation of Gynecology and
Obstetrics (FIGO) staging system
[2]
(Table 1). Preoperative
clinical examination understages 22% of cases
[3]; therefore, gynecologic
oncologists obtain imaging studies preoperatively to stage the tumor and to
predict whether lymph node dissection will be necessary. Lymph node dissection
is necessary if greater than 50% of the myometrial thickness is invaded (FIGO
stage IC) or if the cervix is involved (FIGO stage II). MR imaging is the
current imaging modality of choice. The superiority of MR imaging over
conventional axial CT was determined in a study by Kinkel et al.
[4]. To our knowledge, the
ability of helical CT to stage endometrial carcinoma has not been previously
evaluated.
Materials and Methods
Twenty-five consecutive patients with newly diagnosed endometrial carcinoma
who underwent preoperative enhanced helical CT and subsequent hysterectomy at
our institution between November 2, 1998, and August 30, 1999, were included.
Patients ranged from 44 to 84 years old (mean age, 69 years).
CT was performed with a CTI helical scanner (General Electric Medical
Systems, Milwaukee, WI). Oral contrast agent was administered, and then
iodinated contrast agent (100 mL of ionic or nonionic) was administered IV.
After 60 sec, 7-mm axial images through the liver and "early" 5-mm
axial images through the uterus were obtained. Last, 7-mm axial images from
the inferior edge of the liver through the remainder of the abdomen and pelvis
were obtained so that the uterus was scanned a second time on delayed images.
Early thin sections of the uterus were enlarged for interpretation by scanning
them on a small field of view.
Three blinded observers, all with expertise in gynecologic imaging,
independently and retrospectively evaluated the helical CT scans for the
following two variables: first, what was the depth of myometrial invasion by
tumor? Was it superficial, with less than 50% of the myometrial thickness
invaded by tumor (FIGO stages IA and IB)? Was it deep, with greater than 50%
of the myometrial thickness invaded by tumor (FIGO stage IC)? Second, does the
tumor involve the cervix? (yes = FIGO stage II; no = FIGO stage I).
The time delay between helical CT and hysterectomy ranged from 1 to 17 days
(mean, 6 days). The benchmark for the extent of tumor invasion was determined
pathologically after hysterectomy.
The local standard of care was the use of intraoperative pathologic
evaluation of the hysterectomy specimen to direct lymph node dissection. CT of
the uterus did not direct surgery or other therapy.
Results
The cell types of endometrial carcinoma included the following: 18 (72%) of
25 endometrioid, one (4%) of 25 clear cell, three (12%) of 25 mucinous, and
three (12%) of 25 papillary serous. Deep myometrial invasion by tumor was seen
in six (24%) of 25 patients, and superficial myometrial invasion occurred in
19 (76%) of 25 patients. Cervical involvement was present in three (12%) of 25
patients and absent in 22 (88%) of 25 patients.
For the detection of deep myometrial invasion, helical CT overstaged 11,
understaged one, and correctly staged 13 patients (Figs.
1A,
2A, and
3A). Helical CT had a
sensitivity of 83% (5/[5+1]) and a specificity of 42% (8/[8+11]).

View larger version (158K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A. 58-year-old woman with endometrial carcinoma. Enhanced
helical CT scan of markedly enlarged uterus shows enhancing myometrium
peripherally and low-density tumor centrally, invading greater than 50% of
myometrial thickness posteriorly. Hysterectomy confirmed invasion of greater
than 95% of myometrial thickness.
|
|

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A. 70-year-old woman with endometrial carcinoma. Enhanced
helical CT scan shows endometrial cavity distended with low-density tumor that
invades greater than 50% of enhancing myometrial thickness in left fundal
region. Hysterectomy confirmed invasion of greater than 90% of myometrial
thickness.
|
|

View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3. 79-year-old woman with endometrial carcinoma. Enhanced
helical CT scan shows irregularly marginated low-density tumor centrally in
endometrial cavity (asterisk), judged by all three radiologists to be
tumor invading greater than 50% of myometrial wall on left. Hysterectomy found
tumor invading only 30% of myometrial thickness. No leiomyoma or other
pathologic explanation for CT findings and subsequent CT overstaging was
found.
|
|
For the detection of cervical invasion, helical CT overstaged six,
understaged three, and correctly staged 15 patients (Figs.
1B and
2B). One patient's cervix could
not be evaluated because of artifact from a hip prosthesis. For detection of
cervical invasion, helical CT had a sensitivity of 25% (1/[1+3]) and a
specificity of 70% (14/[14+6]).

View larger version (161K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B. 58-year-old woman with endometrial carcinoma. Enhanced
helical CT scan shows enlarged ill-defined cervix containing irregularly
marginated low-density tumor centrally. Hysterectomy confirmed cervical
invasion.
|
|

View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B. 70-year-old woman with endometrial carcinoma. Enhanced
helical CT scan of bulky uniformly low-density cervix (asterisk). All
three radiologists incorrectly believed that cervix was invaded by tumor. At
hysterectomy, cervix was unremarkable.
|
|
Discussion
At our institution, helical CT is more readily available than MR imaging,
and gynecologic oncologists are more familiar with the anatomy defined by CT.
Despite improvements in CT and helical CT technology, its ability to stage
endometrial carcinoma is not comparable with that of MR imaging, the current
imaging modality of choice.
Compare our findings of the ability of helical CT to evaluate the depth of
myometrial invasion (sensitivity, 83%; specificity, 42%) with those of MR
imaging in a recent metaanalysis of 25 published studies (sensitivity, 92%;
specificity, 90%)
[3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24].
The sensitivity and specificity of MR imaging was calculated by averaging
those published for each contrast-enhanced MR imaging study in the
metaanalysis
[4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24].
Helical CT is less sensitive and less specific than MR imaging for the
detection of deep myometrial invasion.
Compare our findings of the ability of helical CT to evaluate the presence
of cervical invasion by tumor (sensitivity, 25%; specificity, 70%) with those
of MR imaging in the recent metaanalysis (mean sensitivity, 86%; mean
specificity, 97%)
[3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24].
Helical CT is much less sensitive and less specific than MR imaging for the
evaluation of cervical invasion by tumor.
We were unable to identify any shared characteristics of the uteri or
tumors that helical CT incorrectly staged. We suspected that either the
presence of leiomyomatosis or adenomyosis might have increased the difficulty
of staging correctly with helical CT. Yet neither leiomyomatosis nor
adenomyosis was present in most of the incorrectly staged patients, despite
pathologic evaluation of the entire uterus.
A retrospective evaluation of a small sample is not ideal. The selection of
helical CT rather than MR imaging by the gynecologic oncologists for these
patients may have been influenced by variables that are not readily apparent.
Selection bias alone is unlikely to account for the degree of difference
between the ability of helical CT and that of MR imaging to preoperatively
stage endometrial carcinoma.
All three observers independently commented on their preference for the
sagittal images of the uterus that MR imaging provides. Future studies could
evaluate the use of reconstructed sagittal images of the uterus obtained by
helical CT to preoperatively stage endometrial carcinoma.
The ability of multidetector CT to preoperatively stage endometrial
carcinoma is another potential area for future research. Multidetector CT
technology is not currently available at our hospital.
In conclusion, helical CT is insensitive and nonspecific compared with MR
imaging for the preoperative staging of endometrial carcinoma. MR imaging
remains the imaging modality of choice.
References
-
Barakat RR, Park RC, Grigsby PW, Muss HD, Norris HJ. Corpus:
epithelial tumors. In: Hoskins WJ, Perez CA, Young RC, eds.
Principles and practice of gynecologic oncology. 2nd
ed. Philadelphia: Lippincott-Raven, 1997:859
-896
-
International Federation of Gynecology and Obstetrics.
Annual report on the results of treatment in gynecologic
cancer, vol. 23. Milano, Italy: FIGO,
1988
-
Hricak H, Rubinstein LV, Gherman GM, Karastaedt N. MR imaging
evaluation of endometrial carcinoma: results of an NCI cooperative study.
Radiology
1991;179:829
-832[Abstract/Free Full Text]
-
Kinkel K, Kaji Y, Yu K, et al. Radiologic staging in patients with
endometrial cancer: a meta-analysis. Radiology
1999;212:711
-718[Abstract/Free Full Text]
-
Takahashi K, Yoshioka M, Kosuge H, et al. The accuracy of computed
tomography and magnetic resonance imaging in evaluating the extent of
endometrial carcinoma [in Japanese]. Nippon Sanka Fujinka Gakkai
Zasshi 1995;47:647
-654[Medline]
-
Varpula MJ, Klemi PJ. Staging of uterine endometrial carcinoma with
ultra-low field (0.02 T) MRI: a comparative study with CT. J Comput
Assist Tomogr 1993;17:641
-647[Medline]
-
DelMaschio A, Vanzulli A, Sironi S, et al. Estimating the depth of
myometrial involvement by endometrial carcinoma: efficacy of transvaginal
sonography vs MR imaging. AJR
1993;160:533
-538[Abstract/Free Full Text]
-
Yamashita Y, Mizutani H, Torashima M, et al. Assessment of
myometrial invasion by endometrial carcinoma: transvaginal sonography vs
contrast-enhanced MR imaging. AJR
1993;161:595
-599[Abstract/Free Full Text]
-
Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep
myometrial invasion in endometrial carcinoma: comparison of transvaginal
ultrasound, CT, and MRI. J Comput Assist Tomogr
1995;19:766
-772[Medline]
-
Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG.
Endometrial carcinoma staging by MR imaging. Radiology
1987;162:297
-305[Abstract/Free Full Text]
-
Yazigi R, Cohen J, Munoz AK, Sandstad J. Magnetic resonance imaging
determination of myometrial invasion in endometrial carcinoma.
Gynecol Oncol
1989;34:94
-97[Medline]
-
Harrill CD, Kopecky KK, Weaver SR, Sutton GP. Magnetic resonance
imaging in the preoperative assessment of clinical stage I endometrial
carcinoma. Comput Med Imaging Graph
1990;14:191
-195[Medline]
-
Belloni C, Vigano R, del Maschio A, Sironi S, Taccagni GL, Vignali
M. Magnetic resonance imaging in endometrial carcinoma staging.
Gynecol Oncol
1990;37:172
-177[Medline]
-
Chen SS, Rumancik WM, Spiegel G. Magnetic resonance imaging in
stage I endometrial carcinoma. Obstet Gynecol
1990;75:274
-277[Medline]
-
Karube M. Role of magnetic resonance imaging (MRI) in evaluation of
the extension of endometrial carcinoma [in Japanese]. Nippon Sanka
Fujinka Gakkai Zasshi
1991;43:101
-108[Medline]
-
Hricak H, Hamm B, Semelka RC, et al. Carcinoma of the uterus: use
of gadopentetate dimeglumine in MR imaging. Radiology
1991;181:95
-106[Abstract/Free Full Text]
-
Hirano Y, Kubo K, Hirai Y, et al. Preliminary experience with
gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Radiographics
1992;12:243
-256[Abstract]
-
Sironi S, Taccagni G, Garancini P, Belloni C, DelMaschio A.
Myometrial invasion by endometrial carcinoma: assessment by MR imaging.
AJR
1992;158:565
-569[Abstract/Free Full Text]
-
Ito K, Matsumoto T, Nakada T, Nakanishi T, Fujita N, Yamashita H.
Assessing myometrial invasion by endometrial carcinoma with dynamic MRI.
J Comput Assist Tomogr
1994;18:77
-86[Medline]
-
Atsukawa H, Sasaki H, Tada S. A multivariate analysis of assessment
of myometrial invasion of endometrial carcinoma by magnetic resonance imaging.
Gynecol Oncol
1994;54:298
-306[Medline]
-
Joja I, Asakawa M, Asakawa T, et al. Endometrial carcinoma: dynamic
MRI with turbo-FLASH technique. J Comput Assist Tomogr
1996;20:878
-887[Medline]
-
Seki H, Kimura M, Sakai K. Myometrial invasion of endometrial
carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted
images. Clin Radiol
1997;52:18
-23[Medline]
-
Sironi S, Colombo E, Villa G, et al. Myometrial invasion by
endometrial carcinoma: assessment with plain and gadolinium-enhanced MR
imaging. Radiology
1992;185:207
-212[Abstract/Free Full Text]
-
Minderhoud-Bassie W, Treurniet FE, Koops W, Chadha-Ajwani S, Hage
JC, Huikeshoven FJ. Magnetic resonance imaging (MRI) in endometrial carcinoma;
preoperative estimation of depth of myometrial invasion. Acta
Obstet Gynecol Scand
1995;74:827
-831[Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Grossman, Z. J. Ricci, A. Rozenblit, K. Freeman, F. Mazzariol, and M. W. Stein
Efficacy of Contrast-Enhanced CT in Assessing the Endometrium
Am. J. Roentgenol.,
September 1, 2008;
191(3):
664 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sarna, B. G. Coleman, S. K. Srinivas, and D. A. Torigian
Computed Tomographic and Ultrasonographic Findings of Endometrial Carcinoma Appearing as a Fungating Inguinal Mass
J. Ultrasound Med.,
November 1, 2005;
24(11):
1579 - 1582.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Van Mieghem, S. Gryspeerdt, M. Baekelandt, B. van Holsbeeck, P. Lefere, M. Haspeslagh, and I. Dalle
Papillary Serous Adenocarcinoma of the Endometrium: CT-Pathologic Correlation
Am. J. Roentgenol.,
June 1, 2004;
182(6):
1534 - 1536.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yoshida, T. Kurokawa, K. Kawahara, T. Tsuchida, H. Okazawa, Y. Fujibayashi, Y. Yonekura, and F. Kotsuji
Incremental Benefits of FDG Positron Emission Tomography over CT Alone for the Preoperative Staging of Ovarian Cancer
Am. J. Roentgenol.,
January 1, 2004;
182(1):
227 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|